ATE172541T1 - Verfahren zum nachweis biologischer wechselwirkungen, insbesondere in rezeptorbindungs-assays - Google Patents

Verfahren zum nachweis biologischer wechselwirkungen, insbesondere in rezeptorbindungs-assays

Info

Publication number
ATE172541T1
ATE172541T1 AT94923803T AT94923803T ATE172541T1 AT E172541 T1 ATE172541 T1 AT E172541T1 AT 94923803 T AT94923803 T AT 94923803T AT 94923803 T AT94923803 T AT 94923803T AT E172541 T1 ATE172541 T1 AT E172541T1
Authority
AT
Austria
Prior art keywords
pct
ligand
receptor binding
binding assays
binding
Prior art date
Application number
AT94923803T
Other languages
English (en)
Inventor
Andrew John Garman
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Application granted granted Critical
Publication of ATE172541T1 publication Critical patent/ATE172541T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Semiconductor Lasers (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Length Measuring Devices With Unspecified Measuring Means (AREA)
AT94923803T 1993-08-18 1994-08-17 Verfahren zum nachweis biologischer wechselwirkungen, insbesondere in rezeptorbindungs-assays ATE172541T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939317193A GB9317193D0 (en) 1993-08-18 1993-08-18 Method

Publications (1)

Publication Number Publication Date
ATE172541T1 true ATE172541T1 (de) 1998-11-15

Family

ID=10740691

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94923803T ATE172541T1 (de) 1993-08-18 1994-08-17 Verfahren zum nachweis biologischer wechselwirkungen, insbesondere in rezeptorbindungs-assays

Country Status (8)

Country Link
US (1) US6054282A (de)
EP (1) EP0714514B1 (de)
JP (1) JPH09503291A (de)
AT (1) ATE172541T1 (de)
AU (1) AU7389694A (de)
DE (1) DE69414122T2 (de)
GB (2) GB9317193D0 (de)
WO (1) WO1995005601A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9506197D0 (en) 1995-03-27 1995-05-17 Hoffmann La Roche Inhibition of tau-tau association.
US5928888A (en) * 1996-09-26 1999-07-27 Aurora Biosciences Corporation Methods and compositions for sensitive and rapid, functional identification of genomic polynucleotides and secondary screening capabilities
NZ516848A (en) 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
EP1387390B1 (de) * 1997-06-20 2009-02-18 Bio - Rad Laboratories, Inc. Retentatchromatographievorrichtung und Proteinchipmatrizen mit Anwendungen in Biologie und Medizin
AU7103500A (en) * 1999-09-01 2001-03-26 Medalys Corporation High throughput chemical profiling
GB0100119D0 (en) 2001-01-03 2001-02-14 Univ Aberdeen Materials and methods relating to protein aggregation in neurodegenerative disease
GB0101049D0 (en) 2001-01-15 2001-02-28 Univ Aberdeen Materials and methods relating to protein aggregation in neurodegenerative disease
GB0106953D0 (en) 2001-03-20 2001-05-09 Univ Aberdeen Neufofibrillary labels
WO2002095054A2 (en) * 2001-05-18 2002-11-28 President And Fellows Of Harvard College Method of determining protein interaction inhibitors
EP1534075B1 (de) * 2002-07-12 2009-09-30 Morehouse School of Medicine Verfahren zur identifikation von salzempfindlichen personen
US20040058327A1 (en) * 2002-09-20 2004-03-25 Pan Jeffrey Y Method for using a blank matrix in a continuous format high throughput screening process
MY153198A (en) 2006-03-29 2015-01-29 Wista Lab Ltd Inhibitors of protein aggregation
ES2349322T7 (es) 2006-03-29 2019-10-17 Wista Lab Ltd Sales de 3,7-diamino-10H-fenotiazina y su utilización
WO2009155283A2 (en) * 2008-06-17 2009-12-23 Duke University Radiolabled cyclopamine assay for the smoothened receptor
US9110053B2 (en) * 2010-08-20 2015-08-18 Agilent Technologies, Inc. Dried blood spotting paper device and method
WO2012031294A2 (en) * 2010-09-03 2012-03-08 University Of Maryland, College Park Methods for determining protein ligand binding
AU2011358840B2 (en) 2011-02-11 2017-05-04 TauRx Therapeutics Management Ltd Phenothiazine diaminium salts and their use
WO2017108115A1 (en) * 2015-12-22 2017-06-29 Centre National De La Recherche Scientifique - Cnrs - Device for detecting neurotoxins and process for manufacture thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3645687A (en) * 1970-01-05 1972-02-29 Samuel T Nerenberg Immunodiffusion plate apparatus
US4752562A (en) * 1981-01-23 1988-06-21 Baxter Travenol Laboratories, Inc. Detection of serum antibody and surface antigen by radial partition immunoassay
ES8606559A1 (es) * 1982-10-20 1986-04-01 Wiggins Teape Group Ltd Un metodo de fabricar un papel revestido con resina
GB8305197D0 (en) * 1983-02-24 1983-03-30 Amersham Int Plc Assay methods
US4670381A (en) * 1985-07-19 1987-06-02 Eastman Kodak Company Heterogeneous immunoassay utilizing horizontal separation in an analytical element
US5030558A (en) * 1986-11-07 1991-07-09 Syntex (U.S.A.) Inc. Qualitative immunochromatographic method and device
GB2232486A (en) * 1989-05-30 1990-12-12 Quadrant Bioresources Ltd Immunoassay
DE4037837A1 (de) * 1990-11-28 1992-06-04 Behringwerke Ag Zellfreie rezeptorbindungsteste, ihre herstellung und verwendung
US5264372A (en) * 1991-03-15 1993-11-23 Amylin Pharmaceuticals, Inc. Receptor-based screening methods for amylin agonists and antagonists
CA2104596A1 (en) * 1992-01-06 1993-07-07 Dade International Inc. Multi-test immunochemical reagent and method to use same
CA2105167A1 (en) * 1992-01-14 1993-07-15 Kevin Beaumont Myotonin receptors and screening methods
DE4202848A1 (de) * 1992-01-31 1993-08-05 Boehringer Mannheim Gmbh Analysenelement fuer immunoassays

Also Published As

Publication number Publication date
GB9416583D0 (en) 1994-10-12
US6054282A (en) 2000-04-25
GB9317193D0 (en) 1993-10-06
EP0714514A1 (de) 1996-06-05
GB2281122A (en) 1995-02-22
AU7389694A (en) 1995-03-14
GB2281122B (en) 1997-11-12
EP0714514B1 (de) 1998-10-21
DE69414122T2 (de) 1999-03-11
WO1995005601A1 (en) 1995-02-23
DE69414122D1 (de) 1998-11-26
JPH09503291A (ja) 1997-03-31

Similar Documents

Publication Publication Date Title
ATE172541T1 (de) Verfahren zum nachweis biologischer wechselwirkungen, insbesondere in rezeptorbindungs-assays
ES8702661A1 (es) Un aparato de analisis de ligando receptor para detectar un ligando objetivo en una muestra de fluido.
KR890012165A (ko) 이온-포획 분석방법 및 장치
DE69022286D1 (de) Reagenzien, Verfahren und Testsätze zum Nachweis von Amphetaminen durch einen Fluoreszenz-Polarisations-Immunoassay.
FR2630827B1 (fr) Dispositif et procede pour la determination qualitative et quantitative rapide de la presence d'un ligand reactif dans un fluide
SE7702464L (sv) Reagens till anvendning vid immunkemiska bestemningsmetoder
ATE109685T1 (de) Selbstständige testanordnung.
ES2119369T3 (es) Dispositivo sensor para un ensayo sandwich.
ES8302313A1 (es) "metodo para ensayar reacciones antigeno-anticuerpo".
ATE116443T1 (de) Festphasenanalytische vorrichtung und verfahren zum gebrauch derselben.
ATE208900T1 (de) Verringerung des hook-effekts in immuntests mit teilchenförmigem trägermaterial
DE59007200D1 (de) Verfahren zur Bestimmung eines Analyten.
AU619183B2 (en) A one-step immunoassay for the determination of antigen-specific antibodies of one of the immunoglobulin classes a,m,d or e, and an agent suitable for this purpose
ATE545019T1 (de) Mikrofluidisches extraktionsverfahren
FR2771173B1 (fr) Procede de test d'un dispositif d'embrayage automatise
DE69636013D1 (de) Verfahren zum erlangen von rezeptor-freigabeligand (reland)-komplexen und testansätze
DK0774116T3 (da) Fremgangsmåde til screening af biblioteker af forbindelser
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren
DE69922680D1 (de) Detektion und quantifikation von vancomycin in den biologischen flüssigkeiten
DE59711357D1 (de) Immunassay zum Nachweis von anti-B. burgdorferi Antikörpern und Verfahren zur Serodiagnose bei Lyme Borreliose, diagnostische Mittel und Testkits zur Durchführung der Verfahren
Dorward et al. Methods for purifying and detecting IGM antibodies
IT1271870B (it) Metodo immunocitometrico per il rilevamento di linfociti apoptotici.
MX9705543A (es) Procesos y compuestos para la deteccion magnetorrelaxometrica de analitos y su uso.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties